RE:RE:RE:RVX-Illiquid stockI think it is illiquid because the company is poorly managed, poorly promoted and has zero analyst coverage by analysts associated with credible investment houses. I know a number of people who have said they would not buy RVX until such time that the company can provide credible third party (non-stakeholder) affirmation of the claims they make. They thionk I am a loon for having money in this. Those of us who base our investment on our own judgement, own DD and the involvement of large, high quality investors are the exception not the rule as far as retail investors go. As far as I can see anyway.
As far as 40% insider ownership goes, it still means there are about 60 million shares floating around out there to trade. Esperion I believe has over 60% ownership by insiders and 5% owners and it still manages to trade 6 digit volumes daily despite having only about 25 million shares outstanding and a much higher share price. But they have their act together in every respect. Personally I think it would be great for RVX to get their management act together, get some credible analyst coverage, do a share consolidation and get on the NASDAQ, especially if they get FDA trial approval. As I've said on one of these boards you have to look hard to find a ph3 biotech with as much market potential as RVX that has such a pitiful market cap. Management should be ashamed of themselves.